AGC Bio secures lentiviral contract; Thermo Fisher to make Cybin asset

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more. AGC Biologics is partnering with Quell Therapeutics, the companies announced Thursday. AGC ...

Related Posts

Trump's drug price plan is light on details, may have l...

May 12, 2025  0

Iovance stock plummets after lowered full-year guidance

May 9, 2025  0

AI biotech Insilico Medicine goes for third attempt at ...

May 9, 2025  0

Comments

Name

Email

Comment

Post Comment